Home › Funds › TCG Crossover Management, LLC › ABVX

TCG Crossover Management, LLC position in ABVX

ABIVAX SA · Health Care

TCG Crossover Management, LLC reported holding 6,007,834 shares of ABVX (ABIVAX SA) in its Q2 2026 13F filing — a position valued at US$800.6M, representing 19.24% of its reported portfolio and ranking #1 among its reported holdings. TCG Crossover Management, LLC has disclosed ABVX holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

Latest position (Q2 2026)6.01M sh
Reported value held$800.60M
Portfolio Weight19.24%
First reportedQ4 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How TCG Crossover Management, LLC's ABVX position evolved

TCG Crossover Management, LLC first disclosed a stake in ABVX in Q4 2023 at 1,100,000 shares (US$11.8M). The position peaked in Q4 2025 at 7,111,596 shares, worth US$959.0M. Across 11 filings, TCG Crossover Management, LLC increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 6 time(s). The most recent filing (Q2 2026) shows 6,007,834 shares valued at US$800.6M — a reduction of -473,251 shares quarter over quarter.. Notable position changes include a 451% increase in Q2 2024 (shares fell 13% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 1.10M $11.77M New
Q1 2024 1.10M $15.73M Hold
Q2 2024 6.06M $80.07M Add
Q3 2024 6.06M $69.77M Hold
Q4 2024 6.06M $44.33M Hold
Q1 2025 6.06M $37.85M Hold
Q2 2025 6.06M $46.33M Hold
Q3 2025 7.11M $603.77M Add
Q4 2025 7.11M $959.03M Hold
Q1 2026 6.48M $721.67M Reduce
Q2 2026 6.01M $800.60M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABVX and 13F data

ABVX (ABIVAX SA) is a Health Care company. 72 other funds we track also report a position in ABVX — the largest reported positions include Helikon Investments Ltd (US$371.4M), Darwin Global Management, Ltd. (US$348.2M), Vestal Point Capital, LP (US$313.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABVX

All ABVX fund holders →

FAQ

How long has TCG Crossover Management, LLC held ABVX?

TCG Crossover Management, LLC has disclosed ABVX holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

What is TCG Crossover Management, LLC's current position in ABVX?

As of Q2 2026, TCG Crossover Management, LLC holds 6.01M shares of ABVX (ABIVAX SA), valued at $800.60M, representing 19.24% of its reported portfolio and ranking #1.

Has TCG Crossover Management, LLC been buying or selling ABVX?

In the latest 13F filing (Q2 2026), TCG Crossover Management, LLC reduced its position in ABVX. The position peaked in Q4 2025 at 7.11M shares.

Which other funds hold ABVX?

Other major institutional holders of ABVX include Helikon Investments Ltd, Darwin Global Management, Ltd., Vestal Point Capital, LP, among 72 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.